Ethyl 1-bromocyclobutanecarboxylate, 95.0%, 500g

10,12-Pentacosadiyn-1-ol, 98%, 1g

5'-bromo-1',2'-dihydrospiro[cyclobutane-1,3'-pyrrolo[2,3-b]pyridine]-2'-one, 95.0%, 500mg

1-tert-Butyl 3-methyl 3-benzyl-4-oxopiperidine-1,3-dicarboxylate, 97%, 100mg

2-(tert-Butyl)anthracene-9,10-dione, 95.0%, 500g

Z-Val-OH, 98.6%, 25g

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 25g

Methyl 5-bromo-2-chloro-3-methoxybenzoate, 98.0%, 250mg

(3S,5S,6S,8R,9S,10R,13S,14S,17S)-10,13-DIMETHYLHEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,6,17-TRIOL, 98%, 250mg

5-Amino-1-(3-methoxyphenyl)-1H-1,2,3-triazole-4-carboxamide, 95.0%, 500mg

3-(4-formyl-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid, 5g

2-Méthyl-2,4-pentanediol, min.99%, pour la synthèse, 100 ml, emballage plastique.

Ester méthylique d'acide palmitique, 97 % min., 25 g, emballage en verre